Comparing Dupilumab vs Rinvoq
| Dupilumab | Rinvoq (upadacitinib) |
|
|---|
| Dupilumab | Rinvoq (upadacitinib) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Eosinophilic Esophagitis, Chronic Rhinosinusitis With Nasal Polyps, Eczema, Prurigo Nodularis, Asthma, Asthma - Maintenance, Atopic Dermatitis, COPD, Urticaria. Dupilumab may also be... View more |
Prescription only
Prescribed for Crohn's Disease, Ankylosing Spondylitis, Atopic Dermatitis, Non-Radiographic Axial Spondyloarthritis, Polyarticular Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Rheumatoid... View more |
Related suggestions Atopic Dermatitis
Popular comparisons
|
|||||||
| More about Dupilumab | More about Rinvoq (upadacitinib) | ||||||||
| Ratings & Reviews | |||||||||
|
Dupilumab has an average rating of 7.3 out of 10 from a total of 525 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 19% reported a negative effect. |
Rinvoq has an average rating of 7.0 out of 10 from a total of 224 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 17% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Dupilumab side effects |
View all Rinvoq side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Rinvoq prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Dupixent | Other upadacitinib brands include: Rinvoq LQ | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
N/A |
14 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 93 drugs are known to interact with Dupilumab:
|
A total of 597 drugs are known to interact with Rinvoq:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
N/A |
August 16, 2019 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.